Clinical trial
Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation
NCT00441844 · University of California, Davis, Other · Completed
Key facts
| NCT number | NCT00441844 |
|---|---|
| Title | Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation |
| Official title | Phase 2 Study Examining the Effect of Simvastatin vs Placebo on Monocyte Function and Inflammation in Patients With Type 1 Diabetes |
| Lead sponsor | University of California, Davis, Other |
| Collaborators | Juvenile Diabetes Research Foundation National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Simvastatin |
| Enrollment | 50 |
| Start date | Oct 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 1, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: